A recent analysis of cell surface markers of metastatic breast cancer-derived MICs as described by Baccelli et al. revealed the expression of epithelial marker EpCAM, hyaluronic acid receptor CD44, integrin associated protein CD47 and hepatocyte growth factor receptor c-Met as a signature for MICs [46]. This evidence concerns the gene MET and breast carcinoma.